746 related articles for article (PubMed ID: 28236514)
1. Familial hematuria: A review.
Plevová P; Gut J; Janda J
Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
[TBL] [Abstract][Full Text] [Related]
2. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
3. Thin basement membrane nephropathy.
Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
[TBL] [Abstract][Full Text] [Related]
4. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
[TBL] [Abstract][Full Text] [Related]
5. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
[TBL] [Abstract][Full Text] [Related]
6. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
7. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
8. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
[TBL] [Abstract][Full Text] [Related]
9. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
[TBL] [Abstract][Full Text] [Related]
10. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
12. Novel heterozygous COL4A3 mutation in a family with late-onset ESRD.
Hoefele J; Lange-Sperandio B; Ruessmann D; Glöckner-Pagel J; Alberer M; Benz MR; Nagel M; Weber LT
Pediatr Nephrol; 2010 Aug; 25(8):1539-42. PubMed ID: 20177710
[TBL] [Abstract][Full Text] [Related]
13. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
[TBL] [Abstract][Full Text] [Related]
15. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
[TBL] [Abstract][Full Text] [Related]
16. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
[TBL] [Abstract][Full Text] [Related]
17. Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.
Rana K; Wang YY; Powell H; Jones C; McCredie D; Buzza M; Udawela M; Savige J
Pediatr Nephrol; 2005 Dec; 20(12):1729-37. PubMed ID: 16235097
[TBL] [Abstract][Full Text] [Related]
18. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y; Ding J
Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
[TBL] [Abstract][Full Text] [Related]
19. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
